Transplantation tolerance: the big picture. Where do we stand, where should we go?
A major goal in organ transplantation has been to safely exploit the natural processes of immune tolerance in order to minimize the dose and duration of drug immunosuppression. In this commentary, I argue that we can learn from how tumours avoid rejection, to evolve a three-stage tolerance-inducing...
Autor principal: | Waldmann, H |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Wiley
2017
|
Ítems similars
-
Transplantation tolerance-where do we stand?
per: Waldmann, H
Publicat: (1999) -
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
per: Inês Barros, et al.
Publicat: (2020-10-01) -
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
per: Aqeel M. Alenazi, et al.
Publicat: (2023-04-01) -
ColVI myopathies: where do we stand, where do we go?
per: Allamand Valérie, et al.
Publicat: (2011-09-01) -
Training Needs Assessment: Where We Are and Where We Should Go
per: Rodrigo Rezende Ferreira, et al.
Publicat: (2013-01-01)